Abstract
In this article, we trace the resolution of Sherley v. Sebelius, the latest legal challenge to federal funding of research using human embryonic stem cells (hESC). Clarifying the current understanding of federal funding restrictions imposed by the Dickey-Wicker Amendment of 1996, we discuss the potential for change to that standard by political opposition both in Congress and in the White House. We conclude by reflecting on an alternative proposed by opponents of hESC research, the use of human-induced pluripotent stem cell (hiPSC) lines of adult origin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
